Shares of The Chemours Company (NYSE:CC – Get Free Report) have been assigned an average rating of “Hold” from the nine ratings firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $23.11.
CC has been the topic of a number of recent research reports. The Goldman Sachs Group dropped their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley dropped their price target on Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. Truist Financial initiated coverage on Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, BMO Capital Markets cut their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research note on Wednesday, February 19th.
View Our Latest Stock Report on Chemours
Institutional Trading of Chemours
Chemours Trading Up 0.2 %
CC opened at $14.63 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. Chemours has a 52 week low of $13.09 and a 52 week high of $29.21. The business’s 50 day moving average is $17.08 and its two-hundred day moving average is $18.42. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 25.66 and a beta of 2.00.
Chemours (NYSE:CC – Get Free Report) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. On average, research analysts predict that Chemours will post 2.03 EPS for the current year.
Chemours Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.84%. The ex-dividend date of this dividend was Friday, February 28th. Chemours’s dividend payout ratio (DPR) is 175.44%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Featured Stories
- Five stocks we like better than Chemours
- Consumer Discretionary Stocks Explained
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Pros And Cons Of Monthly Dividend Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- What Are Earnings Reports?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.